Qrons (QRON) Stock Price, News & Analysis
Company Description
Qrons (OTC Link: QRON) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $1.2M.
QRON has declined 92.1% over the past year. Shares last traded at $0.0111.
For FY2024, Qrons reported revenue of $0 and diluted earnings per share of $0.00.
This page collects what Stock Titan holds for QRON, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Qrons (QRON) stock last closed at $0.0111. Over the past 12 months, the stock has lost 92.1%. At a market capitalization of $1.2M, QRON is classified as a micro-cap stock with approximately 18.0M shares outstanding.
QRON Rankings
Latest News
Qrons has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 2 with negative movement. Key topics include management, clinical trial. View all QRON news →
SEC Filings
Qrons has filed 1 recent SEC filing, including 1 Form 8-K. The most recent filing was submitted on April 6, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all QRON SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
QRON Company Profile & Sector Positioning
Qrons (QRON) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing QRON often look at related companies in the same sector, including Regen Biopharma (RGBPP), Halberd Corp (HALB), Evofem Bioscienc (EVFM), Ayala Pharm (ADXS), and Ocean Biomedical Inc. (OCEA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate QRON's relative position within its industry.